Pirfenidone in Patients with Progressive Fibrotic Interstitial Lung Diseases Other Than Idiopathic Pulmonary Fibrosis (RELIEF): a Double-Blind, Randomised, Placebo-Controlled, Phase 2b TrialJuergen Behr,Antje Prasse,Michael Kreuter,Johannes Johow,Klaus F. Rabe,Francesco Bonella,Reiner Bonnet,Christian Grohe,Matthias Held,Heinrike Wilkens,Peter Hammerl,Dirk Koschel,Stefan Blaas,Hubert Wirtz,Joachim H. Ficker,Wolfgang Neumeister,Nicolas Schoenfeld,Martin Claussen,Nikolaus Kneidinger,Marion Frankenberger,Simone Hummler,Nicolas Kahn,Silke Tello,Julia Freise,Tobias Welte,Petra Neuser, Andreas GuentherThe Lancet Respiratory medicine（2021）引用 237|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
